Five years since the WHO declared Covid-19 a global pandemic, Europe is still taking stock of what’s changed and what hasn’t.
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone ...
According to Research by SNS Insider, The DNA Sequencing Market Growth is Driven by Technological Advancements and Rising Demand for Precision MedicineAustin, April 04, 2025 (GLOBE NEWSWIRE) -- DNA ...